skip to content

Materials Engineering & Material-Tissue Interactions

Division C - Department of Engineering

Glioblastoma multiforme (GBM) is the most common primary brain tumour, its most malignant form. GBM exhibits an extensive, rapid and infiltrative growth pattern. Prognoses and patient quality of life are poor, due in part to the non-specific and toxic nature of conventional treatment options (chemotherapy and radiation therapy), hence there is a pressing need for new and more targeted therapeutic options. The group aims to test the efficacy of novel immuno-therapeutic treatments. Understanding GBM cell migration and the factors that affect cell adhesion are important for the development of novel therapeutic strategies. The project is carried out in collaboration with Dr Colin Watts (Department of Clinical Neurosciences, Division of Neurosurgery, Addenbrooke's Hospital).


People specializing in this area

 Agavi  Stavropoulou-Tatla
PhD Student
Jesus College
+44 (0)1223 748524
Dr Athina E Markaki
Fellow of Robinson College
+44 (0)1223 766417